| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
| 02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 02/08/2007 | US20070031434 Uses for Eph receptor antagonists and agonists |
| 02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031411 Vaccine comprising a tick cement protein |
| 02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
| 02/08/2007 | US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy |
| 02/08/2007 | US20070031392 Delivery vehicle for recombinant proteins |
| 02/08/2007 | US20070031390 Methods and compositions for site-specific genomic expression of nucleic acid sequences |
| 02/08/2007 | US20070031389 Using cardiac graft to treat and prevent scar tissue on heart; tissue engineering and regenerative medicine |
| 02/08/2007 | US20070031383 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 02/08/2007 | US20070031382 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 02/08/2007 | US20070031381 Recombinant adenoviral vector and method of use |
| 02/08/2007 | US20070031380 Integration-site directed vector systems |
| 02/08/2007 | US20070031379 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 02/08/2007 | US20070031378 Minicircle vector production |
| 02/08/2007 | US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031335 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/08/2007 | DE19858005B4 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles |
| 02/08/2007 | DE102005036880A1 Stereoselektive Synthese von chiralen Diolen Stereoselective synthesis of chiral diols |
| 02/08/2007 | DE102005036542A1 CTL-Prodrug CTL prodrug |
| 02/08/2007 | CA2625909A1 Development of pcr primers and primer mixtures for amplification of cnp60 target sequences |
| 02/08/2007 | CA2621981A1 Dehydrin gene from avicennia marina responsible for conferring salt tolerance in plants |
| 02/08/2007 | CA2619383A1 Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp |
| 02/08/2007 | CA2618050A1 Antibodies directed against an ldl receptor |
| 02/08/2007 | CA2618044A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | CA2617832A1 Yeast host, transformant and method for producing heterologous proteins |
| 02/08/2007 | CA2617792A1 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/08/2007 | CA2617611A1 Production of reprogrammed cells with restored potential |
| 02/08/2007 | CA2617594A1 Polysaccharide synthases |
| 02/08/2007 | CA2617592A1 Genes involved in the biosynthesis of thiocoraline and heterologous production of same |
| 02/08/2007 | CA2617561A1 Multivalent rna nanoparticles for delivery of active agents to a cell |
| 02/08/2007 | CA2617138A1 Mutant timp-3 |
| 02/08/2007 | CA2616987A1 Mutated pseudomonas exotoxins with reduced antigenicity |
| 02/08/2007 | CA2616891A1 Hepatitis c antivirals |
| 02/08/2007 | CA2616799A1 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 02/08/2007 | CA2616579A1 Selection system for maize transformation |
| 02/08/2007 | CA2616535A1 Development of novel germplasm using segregates from transgenic crosses |
| 02/08/2007 | CA2547043A1 A plasma source and applications thereof |
| 02/07/2007 | EP1749893A2 Nucleic acid primers of acidophilic bacterium and method of identifying acidophilic bacterium |
| 02/07/2007 | EP1749889A1 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 02/07/2007 | EP1749888A2 Soluble zalpha11 cytokine receptors |
| 02/07/2007 | EP1749887A2 Phytase polypeptides |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749885A2 Infectious and attenuated bovine viral diarrhea virus clones; methods for their production and use |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749840A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 02/07/2007 | EP1749839A1 Antigen binding polypeptides against F4(K88) fimbriae |
| 02/07/2007 | EP1749838A1 Interleukin-18-receptor proteins |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749834A1 Insect-resistant transgenic plants and methods for improving delta-endotoxin activity against target insects |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749210A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 02/07/2007 | EP1749102A2 Transgenic animals and uses thereof |
| 02/07/2007 | EP1749101A2 Polyketides and their synthesis |
| 02/07/2007 | EP1749098A2 Chimeric adenoviruses for use in cancer treatment |
| 02/07/2007 | EP1749097A2 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 02/07/2007 | EP1749096A1 Method for the production of suitable dna constructs for specific inhibition of gene expression by rna interference |
| 02/07/2007 | EP1749095A2 Novel therapeutic targets in cancer |
| 02/07/2007 | EP1749094A2 Method and tools for analysis of nucleic acids |
| 02/07/2007 | EP1749029A2 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 02/07/2007 | EP1749028A1 Chimeric soluble hyper il-11 and use thereof |
| 02/07/2007 | EP1749022A2 Methods for cyclizing synthetic polymers |
| 02/07/2007 | EP1748954A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/07/2007 | EP1748796A2 Multilayered nanomedicine delivery system and method |
| 02/07/2007 | EP1748782A2 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 02/07/2007 | EP1706491A4 Toxin complex proteins and genes from xenorhabdus bovienii |
| 02/07/2007 | EP1689862A4 Tomatoes having reduced deoxyhypusine synthase activity caused by non-transgenic alterations in a deoxyhypusine synthase gene |
| 02/07/2007 | EP1556491A4 Herbicide-resistant plants, and polynucleotides and methods for providing same |
| 02/07/2007 | EP1504258A4 Multi-functional microarrays and methods |
| 02/07/2007 | EP1497634A4 Protein knobs |
| 02/07/2007 | EP1311675B1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 02/07/2007 | EP1276859B1 Targeted modification of chromatin structure |
| 02/07/2007 | EP1272609B1 Single chain antibody against mutant p53 |
| 02/07/2007 | EP1230373B1 Use of a class of enzymes and their encoding genes to increase the oil content in transgenic organisms |
| 02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 02/07/2007 | EP1194580B1 In vitro reconstitution of segmented negative-strand rna viruses |
| 02/07/2007 | EP1141308B1 Group b streptococcus proteins, and their use |
| 02/07/2007 | EP1093334B8 Development of novel, highly chemoprotectant crucifer germplasm |
| 02/07/2007 | EP1092029B1 Human thrombopoietin mutein |
| 02/07/2007 | EP1019512B1 Method for producing branched fatty acids using genetically modified plants |
| 02/07/2007 | EP1004663B1 Process and microorganism for producing purine nucleosides via fermentation |
| 02/07/2007 | EP0948646B1 Methods for identifying genes essential to the growth of an organism |
| 02/07/2007 | EP0939810B1 Transcriptional intermediary factor-2 tif2 |
| 02/07/2007 | EP0909272B1 Helicobacter pylori adhesin binding group antigen |
| 02/07/2007 | EP0893506B1 Hyaluronan synthase polypeptide of human-origin and dna encoding the same |
| 02/07/2007 | EP0870022B1 Immunostimulatory composition and method |
| 02/07/2007 | EP0833906B1 Novel ctla4/cd28 ligands and uses therefor |
| 02/07/2007 | EP0796344B1 Method of detection of nucleic acids with a specific sequence composition |
| 02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
| 02/07/2007 | CN1910293A Detection of mutations in a gene associated with resistance to viral infection, OASI |
| 02/07/2007 | CN1910288A Integrase fusion proteins and their use with integrating gene therapy |
| 02/07/2007 | CN1910287A Rodent expression systems utilising polyoma virus and epstein barr virus sequences |
| 02/07/2007 | CN1910286A Method for producing l-threonine using recombinant enterobacteriaceae with increased enolase activity |
| 02/07/2007 | CN1910285A Method for the genetic modulation of the biosynthesis of hemicelluloses, cellulose and uronic acids in plant cells using gene expression cassettes |
| 02/07/2007 | CN1910284A Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 02/07/2007 | CN1910283A Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 02/07/2007 | CN1910282A Biosensors based on directed assembly of particles |